VMDGF (Klea Holding) Moat Score: 1/10 (As of Jul. 03, 2026)


VMDGF Klea Holding VMDGF
37 GF Score
Price $0.20
GF Value $0.37
! 2 Warning Signs
View Full Analysis

What is Klea Holding Moat Score?

Klea Holding VMDGF 37 Moat Score is 1 as of Jul. 03, 2026. GuruFocus rates VMDGF with a GF Score™ of 37/100 and a GF Value™ of $0.37. The stock has 2 warning signs investors should review. Among 216 Medical Diagnostics & Research companies, Klea Holding ranks better than 65.74% on this metric.

Klea Holding has the Moat Score of 1, which implies that the company might have No Moat - Very weak/transient advantages.

Klea Holding has No Moat: Klea Holding shows no discernible competitive advantages. It lacks market leadership, brand strength, and significant customer switching costs, resulting in a very weak moat.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Klea Holding might have No Moat - Very weak/transient advantages.

Klea Holding  (OTCPK:VMDGF) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Klea Holding Moat Score Related Terms

VMDGF vs TMO, DHR, IDXX: Moat Score Comparison

For the Diagnostics & Research subindustry, Klea Holding's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Klea Holding Moat Score vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Klea Holding's Moat Score distribution charts can be found below:

* The bar in red indicates where Klea Holding's Moat Score falls into.


VMDGF
37GF Score
Klea Holding VMDGF
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 1 mean?
Klea Holding (VMDGF) has a Moat Score of 1 as of Jul. 03, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Klea Holding ranks #74 out of 216 companies in the Medical Diagnostics & Research industry, placing it in the top 34.3%.
Is Klea Holding's Moat Score too high?
Klea Holding's current Moat Score is 1. Based on the distribution chart, Klea Holding ranks #74 out of 216 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Klea Holding has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does Klea Holding's Moat Score compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Klea Holding ranks #74 out of 216 companies for Moat Score. This puts Klea Holding in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Diagnostics & Research company?
A good Moat Score depends on the Medical Diagnostics & Research industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Klea Holding's current Moat Score is 1. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Klea Holding stock overvalued right now?
Klea Holding (VMDGF) has a current Moat Score of 1. The stock's GF Value™ is $0.37, compared to a current price of $0.20 — trading 45.9% below its estimated fair value. The current Moat Score is 1. Klea Holding's overall GF Score™ is 37/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Klea Holding (VMDGF), the current Moat Score is 1 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Klea Holding (VMDGF) Overvalued in 2026?

Based on GuruFocus' analysis, Klea Holding stock appears to be undervalued. The current stock price of $0.20 is trading 45.9% below its estimated GF Value™ of $0.37.

Key valuation signals for VMDGF:

  • Moat Score: 1
  • GF Value™: $0.37 vs. price of $0.20 (45.9% below fair value)
  • GF Score™: 37/100 with 2 warning signs

No single metric tells the full story. See the VMDGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Klea Holding Business Description

Other Exchanges ALKLH:France7V91:Germany
Address 8, Avenue Kleber, Paris, FRA, 75116
Klea Holding focused on the acquisition, development and digitalization of companies in multiple sectors. Its development of Smart Salem, the first network of digital medical analysis centers accredited by the Dubai Ministry of Health (DHA) in the Emirates United Arabs, or its Smart Health joint venture developed in Saudi Arabia.
37GF Score

Get the complete analysis for VMDGF

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.20
Price
$0.37
GF Value